Clinical Trial Detail

NCT ID NCT02212561
Title Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute leukemia

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Selinexor

Cytarabine

Cytarabine + Dexamethasone + Methotrexate

Fludarabine

Age Groups: adult child

No variant requirements are available.